Trial is looking at effectiveness of hydroxychloroquine with and without azithromycin. Results expected by July.
Researchers are now enrolling outpatients with COVID-19 for a randomized controlled trial of the effectiveness of two drug regimens – hydroxychloroquine and hydroxychloroquine with azithromycin.
In this Q&A, Hilary Godwin, dean of the University of Washington School of Public Health, explains why it makes sense for groups of states, such as Washington, Oregon and California, to coordinate their plans.
Governors are walking a tightrope as they try to figure out how to safely ease off social distancing restrictions and restart their economies without triggering a new surge in coronavirus cases.
Are our pets at risk for COVID-19?
Recent reports of animals testing positive for the novel coronavirus—including a cat in Belgium, a dog in Hong Kong and, famously, a tiger in the Bronx Zoo—have pet owners worrying about their furry companions. Many also wonder whether pets can pass COVID-19 on to people.
Experts at the UW Department of Global Health are actively engaged in COVID-19 research, learning, and service activities to help mitigate the global pandemic.
From testing patients and implementing measures to prevent outbreaks, to vaccine research, and prevention and treatment studies, our team is working to slow COVID-19.
While the U.S. and Europe battle to slow the spread of the novel coronavirus, I can’t help but think about how Africa will cope when it becomes the next epicenter. Based on the three-month-old data that we have about the virus and its spread, guidelines on prevention, containment and mitigation have been set by the World Health Organization (WHO). So far, several African governments have adopted the U.S. and European approach that is centered on lockdowns, social distancing and frequent hand washing with soap and water.
The following is a transcript of an interview with Dr. Christopher Murray that aired Sunday, April 12, 2020, on "Face the Nation."
Newly reported research findings may help in detecting and preventing the spread of COVID19 at independent and assisted living community for senior adults.
One of the valuable lessons from the study at an affected retirement center in Seattle: Health-professionals should not rely solely on symptoms to determine if an older adult should receive a lab test for the coronavirus.
Even before the COVID-19 pandemic, health departments had limited staff, resources and time to support the diverse public health needs of our communities. This system will be further strained as the epidemic grows. We must immediately create a national public health reserve to shore up public health systems.
Things are still getting worse. The US death toll crossed 14,000 on Wednesday, with a record 1,858 deaths reported just on Tuesday. Since the outbreak started, about 425,000 cases have been diagnosed in the US. And researchers say the peak has yet to come.
The Coler Lab at Seattle Children’s Research Institute is using their expertise to support the clinical trial of an experimental coronavirus vaccine funded by National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. National Institutes of Health. The trial is being conducted at the Kaiser Permanente Washington Health Research Institute in Seattle, part of NIAID’s Infectious Diseases Clinical Research Consortium.